Superoxide dismutase induces G1-phase cell cycle arrest by down-regulated expression of Cdk-2 and cyclin-E in murine sarcoma S180 tumor cells

Cell Biochemistry and Function

Volumn 31, Issue 4, 2013, Pages 352-359

  Liu, Dongyue ^a   Liu, Anjun ^a  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antitumor; Cell cycle arrest; S180 tumor cells; Superoxide anion; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE; DNA; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FIBROBLAST; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SARCOMA 180; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; NIH 3T3 CELLS; PROLIFERATING CELL NUCLEAR ANTIGEN; SARCOMA; SUPEROXIDE DISMUTASE;

MURINAE;

EID: 84878738022     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2912     Document Type: Article

References (44)

1. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441-1444.
2. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002; 3: 420-425.
3. Teoh MLT, Turner PV, Evans DH. Tumorigenic poxviruses up-regulate intracellular superoxide to inhibit apoptosis and promote cell proliferation. J Virol 2005; 79: 5799-5811.
4. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40.
5. Inoue M, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003; 10: 2495-2505.
6. 2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci USA 2008; 105: 7147-7152.
7. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96-109.
8. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-798.
9. Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10: 241-252.
10. Ishikawa K, Takenaga K, Akimoto M, et al. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis. Science 2008; 320: 661-664.
11. Manda G, Nechifor MT, Neagu T. Reactive oxygen species, cancer and anti-cancer therapies. Curr Chem Biol 2009; 3: 342-366.
12. Xu R, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug-resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005; 65: 613-621.
13. Indo HP, Davidson M, Yen HC, et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007; 7: 106-118.
14. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Update 2004; 7: 97-110.
15. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
16. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
17. Filomeno G, Rotilio G, Ciriolo MR. Disulfide relays and phosphorylative cascades: partners in redox-mediated signalling patways. Cell Death Differ 2005; 12: 1555-1563.
18. Sun Y, Oberley LW, Oberley TD, Elwell JH, Sierra-Rivera E. Lowered antioxidant enzymes in spontaneously transformed embryonic mouse liver cells in culture. Carcinogenesis 1993; 14: 1457-1463.
19. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390-395.
20. Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 2005; 59: 169-174.
21. Okada F, Shionoya H, Kobayashi M, et al. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. Brit J Cancer 2006; 94: 854-862.
22. Safford SE, Oberley TD, Urano M, St Clair DK. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res 1994; 54: 4261-4265.
23. Yoshizaki N, Mogi Y, Muramatsu H, Koike K, Kogawa K, Niitsu Y. Suppressive effect of recombinant human Cu, Zn-superoxide dismutase on lung metastasis of murine tumor cells. Int J Cancer 1994; 57: 287-292.
24. Muramatsu H, Kogawa K, Tanaka M, et al. Superoxide dismutase in SAS human tongue carcinoma cell line is a factor defining invasiveness and cell motility. Cancer Res 1995; 55: 6210-6214.
25. Du G, Han G, Zhang S, et al. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1α inhibition. Eur J Pharmacol 2010; 630: 121-130.
26. Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 2002; 62: 1205-1212.
27. Lam EW, Zwacka R, Engelhardt JF, et al. Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells. Cancer Res 1997; 57: 5550-5556.
28. Bravard A, Beaumatin J, Dussaulx E, Lesuffleur T, Zweibaum A, Luccioni C. Modifications of the anti-oxidant metabolism during proliferation and differentiation of colon tumor cell lines. Int J Cancer 1994; 59: 843-847.
29. Plymate SR, Haugk KH, Sprenger CC, et al. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene 2003; 22: 1024-1034.
30. Lu M, Gong X, Lu Y, Guo J, Wang C, Pan Y. Molecular cloning and functional characterization of a cell-permeable superoxide dismutase targeted to lung adenocarcinoma cells: Inhibition cell proliferation through the Akt/p27kip1 pathway. J Biol Chem 2006; 281: 13620-13627.
31. John PCL, Mews M, Moore R. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division. Protoplasma 2001; 216: 119-142.
32. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res 1997; 80: 418-426.
33. Rivera A, Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 2005; 280: 29346-29354.
34. Fink B, Laude K, McCann L, Doughan A, Harrison DG, Dikalov S. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol 2004; 287: C895-C902.
35. Maga G, Hübscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003; 116: 3051-3060.
36. Nigg EA. Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. Bioessays 1995; 17: 471-480.
37. Liu D, Liu A. Administration of Vitamin E prevents thymocyte apoptosis in murine sarcoma S180 tumor bearing mice. Cell Mol Biol 2012; 58: OL1671-1679.
38. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-794.
39. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103: 1055-1066.
40. Storz P. Reactive oxygen species in tumor progression. Front Biosci-Landmark 2005; 10: 1881-1896.
41. Israels ED, Israels LG. The Cell Cycle. Oncologist 2000; 5: 510-513.
42. Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28: 2925-2939.
43. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505-514.
44. Koundrioukoff S, Jónsson ZO, Hasan S, et al. A Direct Interaction between Proliferating Cell Nuclear Antigen (PCNA) and Cdk2 Targets PCNA-interacting Proteins for Phosphorylation. J Biol Chem 2000; 275: 22882-22887.